Literature DB >> 3919970

Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry.

D S Millington, T P Bohan, C R Roe, A L Yergey, D J Liberato.   

Abstract

Urine samples from three children at different stages of chronic valproate therapy were partially purified using a cation exchange column. A signal consistent with either valproylcarnitine or octanoylcarnitine was observed in one of these extracts by direct fast atom bombardment-mass spectrometry analysis. These isomeric acylcarnitines were synthesized, separated and characterized by thermospray high performance liquid chromatography-mass spectrometry. This new technique was then employed to positively identify intact valproyl-carnitine in the patients' urine samples. The implications of this finding with regard to a mechanism to account for carnitine deficiency in patients receiving valproate are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919970     DOI: 10.1016/0009-8981(85)90020-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  15 in total

1.  Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.

Authors:  Noboru Okamura; Shuichi Ohnishi; Hiroyuki Shimaoka; Ryo Norikura; Hiroshi Hasegawa
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 2.  Acylcarnitines in intermediary metabolism.

Authors:  A C Sewell; H J Böhles
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

Review 3.  Carnitine esters in metabolic disease.

Authors:  H Böhles; A Evangeliou; K Bervoets; I Eckert; A Sewell
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

4.  Acetate represents a major product of heptanoate and octanoate beta-oxidation in hepatocytes isolated from neonatal piglets.

Authors:  X Lin; S H Adams; J Odle
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl-CoA dehydrogenase deficiency.

Authors:  R Moore; D S Millington; D Norwood; N Kodo; P Robinson; J F Glasgow
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 6.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 7.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

8.  Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.

Authors:  M F Camiña; I Rozas; M Gómez; J M Paz; C Alonso; S Rodriguez-Segade
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

9.  Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.

Authors:  K Totsuka; K Shimizu; M Konishi; S Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 10.  Metabolism of valproate to hepatotoxic intermediates.

Authors:  T A Baillie
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.